Applied Pharmaceutical Analysis 2020 is Going Virtual!

October 12 - 16, 2020 Main Conference

Short Course - Monday, Oct. 19 - Tuesday, Oct. 20, 2020

 

APA 2020 Plenary Speakers

Richard Yost APA2020   

Professor Richard A. Yost, PhD

Colonel Allen R. and Margaret G. Crow Professor, Department of Chemistry, University of Florida

The Triple Quadrupole: Innovation, Serendipity and Persistence

 
     
Mark Rose APA2020  

Mark Rose, PhD

Director of Drug Metabolism and Pharmacokinetics, CHDI Foundation

The Role of Non-Profits in Drug Discovery and Development

     
rigoberto hernandez  

Professor Rigoberto Hernandez, PhD

Gompf Family Professor of Chemistry, Department of Chemistry, Johns Hopkins University

Value of Diversity, Inclusion and Equity in the Sciences

     
Jack Uetrecht APA2020  

Professor Jack Uetrecht, MD, PhD

Professor of Pharmacy and Medicine, Canada Research Chair in Adverse Drug Reactions, University of Toronto

Predicting the Unpredictable: How the Innate Immune Response to Drugs Predicts Risk

APA 2020 Invited Speakers

Jim Gllick APA2020

Jim Glick, PhD, Section Head, Translational and Investigational Labs, PK Sciences, Novartis

Immunogenecity Data and the Regulatory Landscape: Bioanalytical Lessons Learned from a Recent Biological Licensing Application Approval

  Jaya Goyal APA2020

Jaya Goyal, PhD, Vice President, Bioanalytical, Pharmacology, and Biomarker Development, Wave Life Sciences

Title TBA

         
Chongwoo Yu 

Chongwoo Yu, PhD, Master Clinical Pharmacology Reviewer, DCEP, Office of Clinical Pharmacology, OTS/CDER/OMPT/FDA

"Importance of Bioanalysis in Drug Development"

  Sean Kim APA2020

Sean Kim, PhD, Head, DMPK and Clinical Pharmacology, Blueprint Medicines

"ADME and Clinical Pharmacology of AYVAKIT™"

         
Timothy Mack APA2020

Timothy Mack, PhD, Senior Principal Scientist, Celgene

Title TBA

  Min Meng Denali 

Min Meng, Deputy CEO at Chongqing Denali Medpharma, Co. Ltd

Title TBA

 Barry Jones photo

Barry Jones, PhD, Director, Q2 Solutions

High Resolution Mass Spectrometry and Nano-Flow Liquid Chromatography for Critical Reagent-Free Quantitation of Intact Peptides

 

Andrew Rowland APA2020

Andrew Rowland, PhD, Associate Professor, Flinders Univeristy and Beat Cancer Research Fellow, Cancer Counsil SA

Exosome Markers for Drug Metabolism Pathways

         
 

Bonnie Rup, PhD, Biopharmaceutical Development Expert; Bioanalysis, Immunogenicity, Regulatory, Bonnie Rup Consulting LLC

Title TBA

  Jim Shen APA 2020

Jim Shen, PhD, Director, Bioanalytical Science, Technical Outsourcing Management Lead, Bristol-Myers Squibb

Title TBA

         
 

Sekhar Surapaneni, PhD, Vice President, Nonclinical Disposition Assessment, Bristol-Myers Squibb

Challenges with Ozanimod Approval

   Xiaodong Fang

Xiaodong Fang, PhD, Associate Director, Takeda DMPK

"ddPCR and RT-ddPCR Method Validation for Cell and Gene Therapy Support"

 

         
 Kevin Johnson

Kevin Johnson, PhD, Scientist, Genentech

Distinct Species Differences for Aldehyde Oxidase Metabolism and Observed Kinetic Isotope Effects in In Vitro and In Vivo

  Tu Yian APA2020 

Yu Tian, PhD, Director, Drug Metabolism and Pharmacokinetics, AbbVie

Microbiome Mediated Pro-Drug Metabolism and Application in Gut- Restricted Drug Design

         
unadkat jashvanat APA

Jashvant (Jash) D. Unadkat, PhD, Milo Gibaldi Endowed Professor, Department of Pharmaceutics, School of Pharmacy, University of Washington

Complex DDI and Transporter/Metabolism Interplay: Insights from Extended CL Model

 

Dr. Tee Zhang cropped

 

Tianyi Zhang, PhD, Executive Vice President of Frontage Laboratories Inc., and General Manager of Frontage China

Bioanalytical Method Transfer to Support NMPA and Global Studies Fillings

         
 

Huiyu Zhou, PhD, Head of LC/MS Group, BioMarin Pharmaceuticals

Overcoming ADA Interference by Using a Hybrid LC/MS/MS Method to Qualify a Therapeutic Protein in Human Plasma

   

Joleen T. White, PhD, Bioassay Development Lead at Bill and Melinda Gates Medical Research Institute

Practicing Immunogenicity Risk Assessment on Published PEGylated and Multi-specific Biotherapeutics

Zhang Guodong

Guodong Zhang, PhD, Group Head & Associate Director at Alnylam Pharmaceuticals

Bioanalytical Strategies for RNAi Therapeutic Development

   Edit Tarcsa Edit Tarcsa, PhD, Director, Research Fellow DMPK-BA, AbbVie Bioresearch Center

AbbVie Efforts to Combat COVID19 

Ming Chen

Ming Chen, PhD Student @ School of Public Health, Yale University

"Applications of NGS in Cancer Screening and Early Detection Using ctDNA"

   Robert Strum APA2020

 Robert Strum, PhD, Principal Scientist PK, PD, Metabolism (PDM), Zoetis

"The Utility of HRMS in Quantitative Bioanalysis Labs"

Hiroshi Sugimoto APA 2020 

Hiroshi Sugimoto, PhD, Senior Scientist and Group Leader in Global DMPK, Takeda

"Insights on Digital Droplet PCR Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Therapy"

 

  Carmin Szynal APA2020 

Carmin Szynal, PhD, Scientist Global DMPK Group, AbbVie 

"Analysis of Cleaved Protein from Conditional Intact Molecule Using JESS Technology"

Frank Scheffler

Frank Scheffler, PhD, Head of Business Development and Global Collaboration, Hypha Discovery Limited

How to Secure Access to Difficult-to-Synthesize Metabolites for MIST Compliance: A One-Step Multiple Tool Approach

  image.jpeg 

 Yen Ho, PhD, Cell Therapy Safety Group at BMS

Use of Cell Based Off Target Screening in CART Programs

 Josh Elias

Joshua Elias, PhD, Mass Spectrometry Leader at the CHAN ZUCKERBERG BIOHUB

Mapping Host-Microbe Interactions with Mass Spectrometry

  ChadChristianson headshot 

Chad Christianson, PhD, Senior Principal Scientists, Alturas Analytics, Inc.

Ready, Willing and Stable? Adcice from the LC/MS Experts on Analysis of Unstable Compounds and Drugs

David Schumacher 

 David Schumacher, PhD, Quality Assurance Director @Alturas Analytics

Virtual Realities: Hosting Remote Audits (including the FDA) in a Post-COVID World

     
         

Sessions for APA 2020 Workshops 

Regulated Bioanalysis

Regulatory Bioanalysis

When Bioanalytical Data were Critical to a Drug Product Submission or Approval

Regulatory/Immunogenicity Risk Assessments and Integrated Summary of Immunogenicity

Cell and Gene Therapy Bioanalysis in Regulated Environment

Chinese Bioanalytical Space/Regulatory Environment

Discovery Bioanalysis and New Technologies

New Technology and Platforms for Discovery Bioanalysis

Microbiome/Microbiota

Gene and Cell Therapy

HRMS/HRMS Quan

Mechanistic ADME

Current and Emerging Topics in Transporter and CYP Mediated Drug-Drug Interactions

Unusual Approaches to ADME Studies

Metabolism and Toxicology - Predictive Approaches

ADME Challenges in Drug Approval - Case Studies

Combined Workshop

New Analytical Techniques - Biomarkers, Liquid Biopsy, Imaging

Exosomes (EV) and Biomarkers

 

 

Click to Download 2019 APA Program Guide

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2020 conference online.

APA 2020 will take place on-line, October 11-16th, 2020

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy